<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72579</article-id><article-id pub-id-type="doi">10.7554/eLife.72579</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Stable flow-induced expression of KLK10 inhibits endothelial inflammation and atherosclerosis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-248687"><name><surname>Williams</surname><given-names>Darian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248704"><name><surname>Mahmoud</surname><given-names>Marwa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248688"><name><surname>Liu</surname><given-names>Renfa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248689"><name><surname>Andueza</surname><given-names>Aitor</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248690"><name><surname>Kumar</surname><given-names>Sandeep</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248691"><name><surname>Kang</surname><given-names>Dong-Won</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248692"><name><surname>Zhang</surname><given-names>Jiahui</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248693"><name><surname>Tamargo</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248694"><name><surname>Villa-Roel</surname><given-names>Nicolas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2981-9330</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248695"><name><surname>Baek</surname><given-names>Kyung-In</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248696"><name><surname>Lee</surname><given-names>Hwakyoung</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-248842"><name><surname>An</surname><given-names>Yongjin</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-248698"><name><surname>Zhang</surname><given-names>Leran</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-151554"><name><surname>Tate</surname><given-names>Edward W</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248699"><name><surname>Bagchi</surname><given-names>Pritha</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248700"><name><surname>Pohl</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248701"><name><surname>Mosnier</surname><given-names>Laurent O</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-63304"><name><surname>Diamandis</surname><given-names>Eleftherios P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1589-820X</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-248702"><name><surname>Mihara</surname><given-names>Koichiro</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107774"><name><surname>Hollenberg</surname><given-names>Morley D</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248703"><name><surname>Dai</surname><given-names>Zhifei</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-215864"><name><surname>Jo</surname><given-names>Hanjoong</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1833-372X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Molecular and Systems Pharmacology Program</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Coulter Department of Biomedical Engineering</institution>, <institution>Georgia Institute of Technology</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Biomedical Engineering</institution>, <institution>Peking University</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">Coulter Department of Biomedical Engineering</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Celltrion</institution>, <addr-line><named-content content-type="city">Incheon</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff6"><institution content-type="dept">Department of Chemistry</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff7"><institution content-type="dept">Emory Integrated Proteomics Core</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Biotechnology Core Facility Branch</institution>, <institution>Centers for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Department of Molecular Medicine</institution>, <institution>Scripps Research Institute</institution>, <addr-line><named-content content-type="city">San Diego</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Department of Pathology and Laboratory Medicine</institution>, <institution>Mount Sinai Hospital</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff11"><institution content-type="dept">Department of Physiology and Pharmacology</institution>, <institution>University of Calgary</institution>, <addr-line><named-content content-type="city">Calgary</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-28084"><name><surname>Fisher</surname><given-names>Edward A</given-names></name><role>Reviewing editor</role><aff><institution>New York University Grossman School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hjo@emory.edu</email> (HJ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>01</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e72579</elocation-id><history><date date-type="received"><day>28</day><month>07</month><year>2021</year></date><date date-type="accepted"><day>08</day><month>01</month><year>2022</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72579-v1.pdf"/><abstract><p>Atherosclerosis preferentially occurs in arterial regions exposed to disturbed blood flow (<italic>d-flow</italic>), while regions exposed to stable flow (<italic>s-flow</italic>) are protected. The proatherogenic and atheroprotective effects of <italic>d-flow</italic> and <italic>s-flow</italic> are mediated in part by the global changes in endothelial cell gene expression, which regulates endothelial dysfunction, inflammation, and atherosclerosis. Previously, we identified Kallikrein-Related Peptidase 10 (<italic>Klk10</italic>, a secreted serine protease) as a flow-sensitive gene in mouse arterial endothelial cells, but its role in endothelial biology and atherosclerosis was unknown. Here, we show that KLK10 is upregulated under <italic>s-flow </italic>conditions and downregulated under <italic>d-flow </italic>conditions using <italic>in vivo&amp; </italic>mouse models and <italic>in vitro</italic> studies with cultured endothelial cells (ECs). Single-cell RNA sequencing (scRNAseq) and scATAC sequencing (scATACseq) study using the partial carotid ligation mouse model showed flow-regulated <italic>Klk10</italic> expression at the epigenomic and transcription levels. Functionally, KLK10 protected against <italic>d-flow</italic>-induced permeability dysfunction and inflammation in human artery ECs (HAECs), as determined by NFkB activation, expression of vascular cell adhesion molecule 1 (VCAM1) and intracellular adhesion molecule 1 (ICAM1), and monocyte adhesion. Further, treatment of mice <italic>in vivo</italic> with rKLK10 decreased arterial endothelial inflammation in <italic>d-flow</italic> regions. Additionally, rKLK10 injection or ultrasound-mediated transfection of <italic>Klk10</italic>-expressing plasmids inhibited atherosclerosis in <italic>Apoe</italic><sup>-/-</sup> mice. Moreover, KLK10 expression was significantly reduced in human coronary arteries with advanced atherosclerotic plaques compared to those with less severe plaques. KLK10 is a flow-sensitive endothelial protein that serves as an anti-inflammatory, barrier-protective, and anti-atherogenic factor.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL119798</award-id><principal-award-recipient><name><surname>Jo</surname><given-names>Hanjoong</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL145974</award-id><principal-award-recipient><name><surname>Williams</surname><given-names>Darian</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL139757</award-id><principal-award-recipient><name><surname>Jo</surname><given-names>Hanjoong</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Hwakyoung Lee, is affiliated with Celltrion. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf3"><p>Yongjin An, is affiliated with Celltrion. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf4"><p>Eleftherios P Diamandis, has consulted for Abbott diagnostics and Imaware Disgnostics. The author has no other competing interest to declare..</p></fn><fn fn-type="conflict" id="conf5"><p>Hanjoong Jo, is the founder of FloKines Pharma..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal studies were performed with male C57BL/6 or ApoE-/- mice (Jackson Laboratory), were approved by Institutional Animal Care and Use Committee by Emory University (PROTO201700428), and were performed in accordance with the established guidelines and regulations consistent with federal assurance.</p></fn><fn fn-type="other"><p>Human subjects: Human coronary arteries were obtained from de-identified human hearts not suitable for cardiac transplantation donated to LifeLink of Georgia. Therefore, Emory University determined that this study was an IRB-exempt study.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting file; Source Data files for all western blots and gels have been provided for all applicable figures.Previously Published Datasets: Endothelial reprogramming by disturbed flow revealed by single-cell RNAseq and chromatin accessibility study: Andueza A, Kumar S, Kim J, Kang DW, Mumme HL, Perez JI, Villa-Roel N, Jo H, 2020, https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA646233, NCBI Bioproject, PRJNA646233</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Andueza A</collab><collab>Kumar S</collab><collab>Kim J</collab><collab>Kang DW</collab><collab>Mumme HL</collab><collab>Perez JI</collab><collab>Villa-Roel N</collab><collab>Jo H</collab></person-group><year iso-8601-date="2020">2020</year><source>Endothelial reprogramming by disturbed flow revealed by single-cell RNAseq and chromatin accessibility study</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA646233">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA646233</ext-link><comment>BioProject PRJNA646233</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-72579-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>